Clomixyl 50 mg Kalpa Pharmaceuticals

32,00 

(In Stock)

Category:

Clomiphene Citrate (Clomixyl) is a synthetic non-steroidal drug similar in structure to estrogen. Clomixyl is widely used in post cycle therapy. Having similarity to the estrogen, it can bind to estrogen receptors in the hypothalamus. This effect of Clomiphene Citrate is widely used in the treatment of women with premature ovarian failure and for the induction of ovulation. However, prolonged use of the drug is unsafe, as it increases the risk of developing ovarian cancer.

Both the amateurs and professional athletes often use Clomixyl. Unlike other anabolic steroids or hormones, Clomixyl is not conducive to reducing testosterone levels. Conversely, Clomixyl raises testosterone levels. Almost all anabolic steroids have androgenic and anabolic properties. In some cases, anabolic steroids promote the formation of estrogens. Using the enzyme aromatase it is also converted into the female sex hormone estrogen. Estrogen promotes the development of gynecomastia in bodybuilders. Although bodybuilders like to demonstrate their body, hardly any of them wants to show effeminate chest. Therefore, Clomixyl is used to block the development of gynecomastia. Blocking estrogen receptors, it prevents the development of gynecomastia caused by anabolic steroids.

When Clomixyl blocks estrogen receptors in the brain, the hypothalamus causes the surge of releasing hormone which leads to an increase in the synthesis of sex hormones. Testosterone gives additional impetus to the athlete. Some bodybuilders take Clomixyl only for anabolic effect. Others use it in combination with other steroids and growth hormones.

substance active

Clomid

Amount of substance, mg

50

Formulaire de discharge

compressed

1 compressed, mg

50

manufacturer

Products pharmaceutiques Kalpa

volume de commande

Pacchetto (30 Comprimés)

Reviews

There are no reviews yet.

Be the first to review “Clomixyl 50 mg Kalpa Pharmaceuticals”

Your email address will not be published. Required fields are marked *